Aurora Cannabis climbs on higher Q3 revenue

Aurora Cannabis

10/11/2023 16:35

** Shares of Canadian pot firm Aurora Cannabis  ACB.TO  rise
6.56% to C$0.65
    ** Company reports Q2 revenue of C$63.4 mln ($45.80 mln),
30% higher than a year earlier, helped by growth in global
medical cannabis business
    ** "Experiencing the benefits of diversification across our
cannabis and non-cannabis platforms characterized by stability
in Canada, record revenue in Europe and Australia" - ACB
    ** Company expects Q3 cannabis net revenue to be largely
similar to Q2, with the geographical mix slightly weighted
further towards the international medical segment
    ** Including session's gains, stock down 48% YTD
    

($1 = 1.3843 Canadian dollars)

 (Reporting by Roshia Sabu in Bengaluru)
 ((Roshia.Sabu@thomsonreuters.com))